These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19781791)

  • 21. Human late memory CD8+ T cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production.
    Kim TK; St John LS; Wieder ED; Khalili J; Ma Q; Komanduri KV
    J Immunol; 2009 Nov; 183(10):6167-74. PubMed ID: 19841187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-gamma and TNF-beta.
    Adamthwaite D; Cooley MA
    Immunology; 1994 Feb; 81(2):253-60. PubMed ID: 7908892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis.
    Fitzgerald JE; Ricalton NS; Meyer AC; West SG; Kaplan H; Behrendt C; Kotzin BL
    J Immunol; 1995 Apr; 154(7):3538-47. PubMed ID: 7897233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [TCR alpha beta + CD4- CD8- T cells among the peripheral blood mononuclear cells of myasthenia gravis patients].
    Nagane Y; Utsugisawa K; Matsubara R; Yamagata M; Tohgi H
    No To Shinkei; 1996 Jul; 48(7):644-7. PubMed ID: 8752999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients.
    Macedo C; Donnenberg A; Popescu I; Reyes J; Abu-Elmagd K; Shapiro R; Zeevi A; Fung JJ; Storkus WJ; Metes D
    Transpl Immunol; 2005 Jun; 14(2):109-16. PubMed ID: 15935301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly.
    Ouyang Q; Wagner WM; Zheng W; Wikby A; Remarque EJ; Pawelec G
    Exp Gerontol; 2004 Apr; 39(4):607-13. PubMed ID: 15050296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antititin antibody in early- and late-onset myasthenia gravis.
    Szczudlik P; Szyluk B; Lipowska M; Ryniewicz B; Kubiszewska J; Dutkiewicz M; Gilhus NE; Kostera-Pruszczyk A
    Acta Neurol Scand; 2014 Oct; 130(4):229-33. PubMed ID: 24947881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of multiple antibodies in myasthenia gravis and its clinical significance.
    Wang WW; Hao HJ; Gao F
    Chin Med J (Engl); 2010 Sep; 123(18):2555-8. PubMed ID: 21034627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells.
    Zhang W; Liu JL; Meager A; Newsom-Davis J; Willcox N
    J Neuroimmunol; 2003 Jun; 139(1-2):102-8. PubMed ID: 12799027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myasthenia gravis induces the activation and maturation of lymphocytes in thymoma.
    Takahashi K; Monden Y; Saito S; Kamamura Y; Uyama T
    J Clin Immunol; 1996 Jul; 16(4):190-7. PubMed ID: 8840220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathomechanisms of paraneoplastic myasthenia gravis.
    Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
    Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic diseases associated with thymoma.
    Evoli A; Minicuci GM; Vitaliani R; Battaglia A; Della Marca G; Lauriola L; Fattorossi A
    J Neurol; 2007 Jun; 254(6):756-62. PubMed ID: 17325820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD45 isoform expression in autoimmune myasthenia gravis.
    Tackenberg B; Nitschke M; Willcox N; Ziegler A; Nessler S; Schumm F; Oertel WH; Hemmer B; Sommer N
    Autoimmunity; 2003 Mar; 36(2):117-21. PubMed ID: 12820694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical differences of early and late-onset myasthenia gravis in 985 patients.
    Fan L; Ma S; Yang Y; Yan Z; Li J; Li Z
    Neurol Res; 2019 Jan; 41(1):45-51. PubMed ID: 30311866
    [No Abstract]   [Full Text] [Related]  

  • 39. Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations.
    Xu BY; Giscombe R; Söderlund A; Troye-Blomberg M; Pirskanen R; Lefvert AK
    Clin Exp Immunol; 1998 Sep; 113(3):456-64. PubMed ID: 9737677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymoma-associated immunodeficiency: a syndrome characterized by severe alterations in NK, T and B-cells and progressive increase in naïve CD8+ T Cells.
    Vitiello L; Masci AM; Montella L; Perna F; Angelini DF; Borsellino G; Battistini L; Merola G; De Palma R; Spadaro G; Cosentini E; Palmieri G; Racioppi L
    Int J Immunopathol Pharmacol; 2010; 23(1):307-16. PubMed ID: 20378017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.